Tim Casey

Conference Insider
Overview of Botulinum Toxin Products
02/15/2011
In the past 2 decades, the US Food and Drug Administration (FDA) has approved 4 products containing botulinum toxin; it has also required a risk evaluation and mitigation strategy (REMS) for each product: onabotulinumtoxinA,...
In the past 2 decades, the US Food and Drug Administration (FDA) has approved 4 products containing botulinum toxin; it has also required a risk evaluation and mitigation strategy (REMS) for each product: onabotulinumtoxinA,...
In the past 2 decades, the US...
02/15/2011
First Report Managed Care
Conference Insider
Colorectal Cancer Screening and Colonoscopies
07/22/2013
Orlando—As screening rates for colorectal cancer have increased in recent years, the incidence and death rates due to the disease have declined. Still, approximately 22 million people in the United States have never been screened, and the...
Orlando—As screening rates for colorectal cancer have increased in recent years, the incidence and death rates due to the disease have declined. Still, approximately 22 million people in the United States have never been screened, and the...
Orlando—As screening rates for...
07/22/2013
First Report Managed Care
Treatment Options for COPD
06/19/2014
Orlando—In the United States, half of the 24 million people with chronic obstructive pulmonary disease (COPD) are undiagnosed. Still, a person dies from COPD every 4 minutes. The disease is the fourth leading cause of death and will be the...
Orlando—In the United States, half of the 24 million people with chronic obstructive pulmonary disease (COPD) are undiagnosed. Still, a person dies from COPD every 4 minutes. The disease is the fourth leading cause of death and will be the...
Orlando—In the United States,...
06/19/2014
First Report Managed Care
Combination of Treatment for PAD Yielded Better Results
01/21/2014
Dallas—Patients with peripheral arterial disease (PAD) and intermittent claudication who underwent endovascular revascularization and supervised exercise therapy had a significant improvement in walking distance and quality of life compared...
Dallas—Patients with peripheral arterial disease (PAD) and intermittent claudication who underwent endovascular revascularization and supervised exercise therapy had a significant improvement in walking distance and quality of life compared...
Dallas—Patients with peripheral...
01/21/2014
First Report Managed Care
Opioid Usage and Diabetic Peripheral Neuropathy
08/15/2013
An analysis of a claims database found that 61% of patients with diabetic peripheral neuropathy had not received treatment for the disease.Although if patients took medications, they typically used opioids to manage the condition.
An analysis of a claims database found that 61% of patients with diabetic peripheral neuropathy had not received treatment for the disease.Although if patients took medications, they typically used opioids to manage the condition.
An analysis of a claims database...
08/15/2013
First Report Managed Care
Ranolazine for Type 2 Diabetes, Coronary Artery Disease, and Chronic Stable Angina
04/22/2013
San Francisco—Patients with type 2 diabetes, coronary artery disease, and chronic stable angina who took ranolazine had fewer angina episodes and fewer sublingual nitroglycerin dosages compared with a group receiving placebo, according to a...
San Francisco—Patients with type 2 diabetes, coronary artery disease, and chronic stable angina who took ranolazine had fewer angina episodes and fewer sublingual nitroglycerin dosages compared with a group receiving placebo, according to a...
San Francisco—Patients with type...
04/22/2013
First Report Managed Care
Administration of Telaprevir Twice or 3 Times Daily
12/17/2012
Boston—Patients with hepatitis C had similar sustained virologic response rates after 12 weeks whether they took 1125 mg of telaprevir twice daily or 750 mg of telaprevir every 8 hours, according to a randomized, open-label, multicenter,...
Boston—Patients with hepatitis C had similar sustained virologic response rates after 12 weeks whether they took 1125 mg of telaprevir twice daily or 750 mg of telaprevir every 8 hours, according to a randomized, open-label, multicenter,...
Boston—Patients with hepatitis C...
12/17/2012
First Report Managed Care
Use of Generic Drugs Saved $1.07 Trillion in Past Decade
09/14/2012
To deal with escalating costs, health insurers have proposed several ways to control this problem. Near the top of their list is increasing reliance on generic drugs rather than more expensive branded products since generics, besides being...
To deal with escalating costs, health insurers have proposed several ways to control this problem. Near the top of their list is increasing reliance on generic drugs rather than more expensive branded products since generics, besides being...
To deal with escalating costs,...
09/14/2012
First Report Managed Care
Options to Treat Gout and Increase Medication Adherence
05/24/2012
San Francisco—According to an article in Arthritis & Rheumatism [2008;58(1):26-35], as many as 3 million people in the United States self-reported having gout in 2008. Another study, published online in Arthritis & Rheumatism on July 28,...
San Francisco—According to an article in Arthritis & Rheumatism [2008;58(1):26-35], as many as 3 million people in the United States self-reported having gout in 2008. Another study, published online in Arthritis & Rheumatism on July 28,...
San Francisco—According to an...
05/24/2012
First Report Managed Care
Dosing and Adherence in Patients Taking Tyrosine Kinase Inhibitors
01/25/2012
San Diego—According to a cross-sectional survey of patients with chronic myeloid leukemia (CML) in the United States and Europe, patients who took nilotinib were significantly more likely to have difficulty adhering to their treatment regimen...
San Diego—According to a cross-sectional survey of patients with chronic myeloid leukemia (CML) in the United States and Europe, patients who took nilotinib were significantly more likely to have difficulty adhering to their treatment regimen...
San Diego—According to a...
01/25/2012
First Report Managed Care

Upcoming Events

DCLF
March 17 ⁠–⁠ March 19
WoundCon
March 21
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
March 29 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Psych Congress Regionals
April 3 ⁠–⁠ April 4
Advances in Inflammatory Bowel Disease Regionals
April 5 ⁠–⁠ April 6
Rx summit logo
April 21 ⁠–⁠ April 24
April 29 ⁠–⁠ April 30
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use